NeonMind Biosciences Inc.
NMDBF · OTC
11/30/2022 | 11/30/2021 | 11/30/2020 | 11/30/2019 | |
|---|---|---|---|---|
| Market Cap | $11 | $8,820 | $33,994 | $0 |
| - Cash | $36 | $774 | $1 | $108 |
| + Debt | $847 | $450 | $691 | $0 |
| Enterprise Value | $822 | $8,496 | $34,684 | -$108 |
| Revenue | $0 | $0 | $416 | – |
| % Growth | – | -100% | – | – |
| Gross Profit | $0 | $0 | $416 | – |
| % Margin | – | – | 99.9% | – |
| EBITDA | -$1,474 | -$6,617 | -$2,670 | – |
| % Margin | – | – | -642.1% | – |
| Net Income | -$2,034 | -$7,208 | -$2,677 | – |
| % Margin | – | – | -643.8% | – |
| EPS Diluted | -53.93 | -7.33 | -2.86 | – |
| % Growth | -635.7% | -156.3% | – | – |
| Operating Cash Flow | -$1,081 | -$5,821 | -$853 | – |
| Capital Expenditures | $0 | -$3 | $0 | – |
| Free Cash Flow | -$1,081 | -$5,824 | -$853 | – |